Method of treating inflammation, allergy and asthma with a purified extract (ATC1) isolated from Pseudolysimachion rotundum var. subintegrum containing abundant amount of active ingredient
KR20150116280A
Pharmaceutical composition of pregabalin with improved stability and method for preparing thereof
KR20140122656A
a purified extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundunt amount of catapol derivatives, as an active ingredient for preventing or treating chronic obstructive pulmonary disease
KR20150082906A
Aqueous flowable liquid composition and preparing methode thereof
KR20140087982A
a purified extract isolated from Pseudolysimachion rotundum var. subintegrum containing abundunt amount of active ingredient, the preparation thereof, and the composition comprising the same as an active ingredient for preventing or treating inflammation, allergy and asthma
KR20140138422A
Novel crystalline from of cefditoren pivoxyl and preparation method thereof
KR20140043517A
Pharmaceutical composition of candesartan cilexetil with improved stability and method for preparing thereof
KR20140026953A
Stable composition for skin external application comprising disaturated phospholipids
KR20140017749A
Composition comprising vitamin complex and crude drugs for health promotion
KR20110104903A
Pharmaceutical composition of pramipexole with improved stability and method for preparing thereof
KR20120024067A
Method for purifying cephalosporin antibiotic
KR100844926B1
Quinoline derivatives as caspase-3 inhibitor, preparation process for the same and pharmaceutical composition comprising the same
KR100848491B1
2-thiazolidine derivatives having beta;-amino group, pharmaceutical acceptable salts and preparation process thereof
KR20080067391A
1,4-DIAZEPANE DERIVATIVES HAVING Beta;-AMINO GROUP, PHARMACEUTICAL ACCEPTABLE SALTS AND PREPARATION PROCESS THEREOF
KR20080035067A
Novel crystalline form of amlodipine hydrochloride, its preparation method and pharmaceutical composition comprsing it
KR20080007765A
Purification process of cilastatin
KR100786884B1
Water soluble composition containing coenzyme q10
KR100683231B1
Useful intermediates for preparation of coenzyme q-10, preparation method thereof and preparation methd of coenzyme q-10 using them
KR20070111099A
Novel crystalline form of sitagliptin hydrochloride
KR20070103173A
A composition for skin-care comprising coenzyme q10
